Clinical trial
An Open-Label, 2-Period, Crossover Study to Determine the Effect of Multiple Oral Doses of Ezetimibe 20 mg on the Pharmacokinetics of a Single Oral Dose of Cyclosporine in Young, Healthy, Normal, Male and Female Subjects
NCT00653276 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, 2-Period, Crossover Study to Determine the Effect of Multiple Oral Doses of Ezetimibe 20 mg on the Pharmacokinetics of a Single Oral Dose of Cyclosporine in Young, Healthy, Normal, Male and Female Subjects
- Lead sponsor
- Organon and Co
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- January 31, 2004
- Enrollment
- 13 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cholesterol